Skip to main content
    U

    UnitedHealth Group Incorporated (UNH)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $412.06
    +4.60 (+1.13%)

    Market Cap: $365.09B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    UnitedHealth Group Incorporated (UNH) Earnings: Report Dates and Results

    Updated Oct 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    UnitedHealth Group (UNH) is expected to report earnings on Jan 25, 2027. In the quarter ended Sep 30, 2026, UnitedHealth Group reported EPS of $4.69, above the $4.12 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +5.61%
    Streak
    3 Q

    Upcoming Estimates

    Reports Jan 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$2.29
    Range$2.11 - $2.75
    27 analysts
    Revenue Consensus
    $113.45B
    Range$106.94B - $121.17B
    24 analysts
    Reports Apr 19, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$8.17
    Range$6.53 - $9.06
    16 analysts
    EPS Revisions
    9
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$8.12+0.5%
    60d ago$8.12+0.6%
    30d ago$8.12+0.6%
    7d ago$8.17-0.0%
    Current$8.17
    Revenue Consensus
    $113.70B
    Range$109.70B - $117.62B
    10 analysts

    Next Report

    UNH has an expected report date of Jan 25, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 8.5% above the $2.11 reported for the quarter ended Dec 31, 2025.

    UNH Earnings Call

    The latest UNH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, UNH beat 37, missed 2 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $112.69B, down 0.4% from $113.16B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$4.69$4.12$3.90 - $4.56+13.84%Beat+60.6%232 up, 1 downOct 13, 2026$112.69B
    Jun 30, 2026$6.38$4.94$4.24 - $5.22+29.15%Beat+56.4%232 up, 3 downJul 16, 2026$112.03B
    Mar 31, 2026$7.23$6.60$5.01 - $6.98+9.55%Beat+0.4%23N/AApr 21, 2026$111.72B
    Dec 31, 2025$2.11$2.11$2.02 - $2.310.00%In line-69.0%241 up, 1 downJan 27, 2026$113.22B
    Sep 30, 2025$2.92$2.81$2.22 - $3.57+3.91%Beat-59.2%232 up, 3 downOct 28, 2025$113.16B
    Jun 30, 2025$4.08$4.45$3.39 - $5.48-8.31%Miss-40.0%221 up, 8 downJul 29, 2025$111.62B
    Mar 31, 2025$7.20$7.29$5.89 - $7.91-1.23%Miss+4.2%222 up, 1 downApr 17, 2025$109.58B
    Dec 31, 2024$6.81$6.74$6.42 - $7.00+1.04%Beat+10.6%233 up, 4 downJan 16, 2025$100.81B
    Sep 30, 2024$7.15$7.03$6.85 - $7.11+1.71%Beat+9.0%231 up, 0 downOct 15, 2024$100.82B
    Jun 30, 2024$6.80$6.63$5.86 - $6.87+2.56%Beat+10.7%210 up, 1 downJul 16, 2024$98.86B
    Mar 31, 2024$6.91$6.62$6.22 - $6.80+4.38%Beat+10.4%221 up, 1 downApr 16, 2024$99.80B
    Dec 31, 2023$6.16$5.99$5.90 - $6.02+2.84%Beat+15.4%190 up, 2 downJan 12, 2024$94.43B
    Sep 30, 2023$6.56$6.35$6.14 - $6.73+3.31%Beat+13.3%200 up, 1 downOct 13, 2023$92.36B
    Jun 30, 2023$6.14$5.98N/A+2.68%Beat+10.2%220 up, 9 downJul 14, 2023$92.90B
    Mar 31, 2023$6.26$6.08$5.39 - $7.33+2.96%Beat+14.0%212 up, 0 downApr 14, 2023$91.93B
    Dec 31, 2022$5.34$5.17$5.05 - $5.30+3.29%Beat+19.2%221 up, 0 downJan 13, 2023$82.79B
    Sep 30, 2022$5.79$5.44$5.25 - $5.61+6.43%Beat+28.1%211 up, 1 downOct 14, 2022$80.89B
    Jun 30, 2022$5.57$5.21N/A+6.91%Beat+18.5%N/A0 up, 0 downJul 15, 2022$80.33B
    Mar 31, 2022$5.49$5.35$5.10 - $5.88+2.62%Beat+3.4%203 up, 0 downApr 14, 2022$80.15B
    Dec 31, 2021$4.48$4.31$4.19 - $4.39+3.94%Beat+77.8%230 up, 1 downJan 19, 2022$73.74B
    Sep 30, 2021$4.52$4.42$4.20 - $4.67+2.26%Beat+28.8%23N/AOct 14, 2021$72.34B
    Jun 30, 2021$4.70$4.46$4.25 - $4.64+5.38%Beat-34.0%22N/AJul 15, 2021$71.32B
    Mar 31, 2021$5.31$4.38$3.88 - $4.80+21.23%Beat+42.7%20N/AApr 15, 2021$70.20B
    Dec 31, 2020$2.52$2.41$2.30 - $2.79+4.56%Beat-35.4%21N/AJan 20, 2021$65.47B
    Sep 30, 2020$3.51$3.08$2.54 - $3.80+13.96%Beat-9.5%24N/AOct 14, 2020$65.11B
    Jun 30, 2020$7.12$5.24$3.52 - $7.39+35.88%Beat+97.8%24N/AJul 15, 2020$62.14B
    Mar 31, 2020$3.72$3.65$3.51 - $3.93+1.92%Beat-0.3%23N/AApr 15, 2020$64.42B
    Dec 31, 2019$3.90$3.78$3.72 - $3.89+3.17%Beat+18.9%25N/AJan 15, 2020$61.28B
    Sep 30, 2019$3.88$3.76$3.70 - $3.83+3.19%Beat+13.8%23N/AOct 15, 2019$60.36B
    Jun 30, 2019$3.60$3.46$3.35 - $3.50+4.05%Beat+14.6%24N/AJul 18, 2019$60.61B
    Mar 31, 2019$3.73$3.60$3.52 - $3.64+3.61%Beat+22.7%22N/AApr 16, 2019$59.90B
    Dec 31, 2018$3.28$3.22$3.16 - $3.38+1.86%Beat+26.6%22N/AJan 15, 2019$58.40B
    Sep 30, 2018$3.41$3.30$3.20 - $3.35+3.33%Beat+28.2%22N/AOct 16, 2018$56.56B
    Jun 30, 2018$3.14$3.04$2.99 - $3.11+3.29%Beat+27.6%21N/AJul 17, 2018$56.09B
    Mar 31, 2018$3.04$2.91$2.74 - $3.01+4.47%Beat+28.3%19N/AApr 17, 2018$55.20B
    Dec 31, 2017$2.59$2.52$2.46 - $2.56+2.78%Beat+22.7%21N/AJan 16, 2018$52.07B
    Sep 30, 2017$2.66$2.57$2.47 - $2.68+3.50%Beat+22.6%17N/AOct 17, 2017$50.32B
    Jun 30, 2017$2.46$2.38$2.32 - $2.41+3.36%Beat+25.5%20N/AJul 18, 2017$50.05B
    Mar 31, 2017$2.37$2.17N/A+9.22%Beat+30.9%N/AN/AApr 18, 2017$48.72B
    Dec 31, 2016$2.11$2.07N/A+1.93%Beat+50.7%N/AN/AJan 17, 2017$47.53B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $16.31, down 41.1% from the year before. It was $8.05 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$16.31-41.1%
    Dec 31, 2024$27.67+10.2%
    Dec 31, 2023$25.12+13.2%
    Dec 31, 2022$22.19+16.7%
    Dec 31, 2021$19.01+12.7%
    Dec 31, 2020$16.87+11.6%
    Dec 31, 2019$15.11+17.4%
    Dec 31, 2018$12.87+27.7%
    Dec 31, 2017$10.08+25.2%
    Dec 31, 2016$8.05N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,800 words across 23 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,80223
    2026Q2Jun 30, 20269,38421
    2026Q1Mar 31, 20269,23421
    2025Q4Dec 31, 20258,37518
    2025Q3Sep 30, 20259,17125
    2025Q2Jun 30, 20258,64514
    2025Q1Mar 31, 20258,94221
    2024Q4Dec 31, 20248,69717

    2026Q3 Earnings Call

    Opening remarks

    Steve Hemsley Chairman and CEO Good morning, and thank you for joining us today. Our third quarter performance reflects actions taken throughout 2026, driving meaningful progress and reinforcing our confidence to sustainably grow in 2027 and beyond within our 13%-16% long-term target growth range. Our revised full-year 2026 guidance reflects continuing improvements in leadership and execution across Optum and UnitedHealthcare as we better align our businesses to serve the demands of the ever-changing U.S. healthcare environment. We are accelerating the modernization of our enterprise by advancing simplified and more responsive policies, processes, and tools, focusing on more effective integrated value-based care offerings, and responsibly building modern agentic infrastructure as we seek to ensure people have access to higher-quality care at lower costs, and at the same time, clinicians experience a simpler, faster, and more supportive system. Across the businesses, AI-enabled capabilities are beginning to help clinicians spend more time with patients, improve service speed and experience, streamline administration, and reduce friction for both consumers and clinicians. A few examples. We have expanded AI-enabled chart summarization to more than 40% of our employed clinicians, reducing chart review time by 33%. AI-enabled information gathering and research have shortened appeal cycle times by 26%, improving both member and clinician experience, and we expect this to accelerate in 2027. For this year's Medicare Advantage annual enrollment period, we are introducing AI-powered plan recommendations that use a member's care history and local plan options to help simplify their selection. By the end of this year, we are on track to implement all previously announced prior authorization reforms, reducing decision timelines for patients, relieving administrative burden for clinicians, and delivering better experiences for people. Collectively, these initiatives will reduce total prior authorizations by 30%, including a reduction of two-thirds in prior authorizations for people under the age of 18. These efforts are only the beginning. More will follow. They are central to how we're changing our enterprise to be more in line with our mission, creating greater value and positive social impact. In that vein, an important effort is the reimagined United Health Foundation. With $1 billion committed to date, the foundation's investments, along with the dedicated operational expertise of UnitedHealthcare and Optum, can help facilitate scaled solutions to some of the U.S. health system's greatest challenges, including rural health, maternal and infant health, behavioral health, and workforce education. As just one example, in Tennessee, the foundation is helping expand and operate health hubs across the state, providing underserved communities with access to preventive care and chronic condition support. We will continue to highlight the foundation as part of our commentary on our earnings calls going forward. The broader healthcare environment remains dynamic.

    Frequently Asked Questions About UNH

    When is UnitedHealth Group's next earnings date?

    UnitedHealth Group's next earnings report is expected for Jan 25, 2027.

    Did UNH beat earnings estimates last quarter?

    Yes. UnitedHealth Group reported EPS of $4.69 for the quarter ended Sep 30, 2026, above the $4.12 estimate, a 13.84% surprise.

    What EPS do analysts expect from UNH next quarter?

    The consensus EPS estimate for UnitedHealth Group for the quarter ending Dec 31, 2026 is $2.29 from 27 analysts, with estimates from $2.11 to $2.75.

    How often does UNH beat earnings estimates?

    UnitedHealth Group beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +5.99%.